Meningococcal B vaccine ineffective in gonorrhea prevention for men who have sex with men
medicalxpress - The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled trial (RCT) into possible efficacy published in the Ne…
AI Summary: A major study found that the meningococcal B (MenB) vaccine does not provide protection against gonorrhea in men who have sex with men, contradicting earlier hopes that cross-protection might exist. Researchers emphasize the need for dedicated gonorrhea vaccines and continued public-health measures to control rising infection rates.
Related Stories
Engineered 15‑strain biotherapeutic matches donor FMT for C. difficile / 2 months
One hepatitis B drug shows early functional cures in trial / 3 months
Deep learning discovers antibiotic leads against drug‑resistant gonorrhea / 2 months
Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 3 months
Triple‑dose early treatment clears HIV in newborn primates study / 15 days
Fridge‑free vaccine advances aim to cut massive vaccine wastage / 21 days
UK begins human testing of first AI-designed 'universal' vaccine / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Animal Health, Price Transparency, Hospital Operations, Nutrition and look for the RSS link.
StackHealth Time Machine